Scimedx Phase II PR3 Igg Antibody Eia
FDA 510(k) K010287 · Scimedx Corp.
510(k) numberK010287
Submission
- Device name
- Scimedx Phase II PR3 Igg Antibody Eia
- Applicant
- Scimedx Corp.
Denvill, NJ, US - Received
- January 31, 2001
- Decision date
- March 16, 2001
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) statement available from FDA
Device classification
- Product code
- MOB – Test System, Antineutrophil Cytoplasmic Antibodies (Anca)
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.5660
- Specialty
- Immunology
Other 510(k)s with product code MOB
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K261466 | Alegria Flash MPO; Alegria Flash PR3; Alegria Flash GBMMOB · Traditional | Zeus Scientific | 08/21/2026SE |
| K243776 | Anti-Neutrophil Cytoplasmic Antibodies (Ethanol-Fixed); Anti-Neutrophil Cytoplasmic…MOB · Traditional | Zeus Scientific | 05/07/2025SE |
| K172582 | EUROIMMUN IFA Granulocyte Mosaic EUROPattern and EUROIMMUN EUROPLUS Granulocyte Mosaic…MOB · Traditional | Euroimmun Us, Inc. | 05/24/2018SE |
| K172461 | AESKUSLIDES ANCA Ethanol, AESKUSLIDES ANCA FormalinMOB · Traditional | Aesku.Diagnostics GmbH & Co. KG | 03/23/2018SE |
| K173792 | EliA PR3s Immunoassay; EliA MPOs Immunoassay; EliA GBM ImmunoassayMOB · Traditional | Phadia AB | 03/13/2018SE |
| K161258 | NOVA Lite DAPI ANCA Ethanol Kit, NOVA Lite DAPI ANCA Formalin KitMOB · Traditional | Inova Diagnostics, Inc. | 02/03/2017SE |
| K140225 | Elia PR3S Immunoassay, Elia Mpos Immunoassay, Elia GBM Immunoassay, Elia Anca/Gbm…MOB · Traditional | Phadia US, Inc. | 10/27/2014SE |
| K112545 | Quanta Flash PR3, Quanta Flash Mpo, Quanta Flash GBMMOB · Traditional | Inova Diagnostics, Inc. | 07/31/2012SE |
| K100917 | Fidis Vasculitis Assay Kit and Analyzer and Caris SystemMOB · Special | Biomedical Diagnostics (Bmd) SA | 11/03/2010SE |
| K092601 | Immulisa Anca Screen ElisaMOB · Traditional | Immco Diagnostics, Inc. | 10/07/2010SE |
More from Immco Diagnostics, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K011348 | Phase II GBM Igg Antibody Eia TestMVJ · Traditional | 06/25/2001SE |
| K011082 | Tpo Igg Antibody Eia TestJZO · Traditional | 06/06/2001SE |
| K010625 | Eurospital Eu-Ttg Iga UmanaMVM · Traditional | 04/24/2001SE |
| K010289 | Scimedx Phase II Mpo Igg Antibody EiaMOB · Traditional | 03/07/2001SE |
| K002189 | Gliadin Igg Antibody Eia Detection SystemMST · Traditional | 10/19/2000SE |
| K002169 | Gliadin Iga Antibody Eia Detection SystemMST · Traditional | 10/19/2000SE |
| K002107 | Ifa Kit for the Detection of Endomysial Iga Anibodies Using Primate Umbilical Cord…MVM · Traditional | 08/04/2000SE |
| K994379 | Eu-Ttg Iga ElisaMVM · Traditional | 02/18/2000SE |
| K970198 | Ifa HEP2 Kit for the Detection of Antinuclear AntibodiesDHN · Traditional | 02/20/1997SE |
| K962360 | Ifa Kit for the Detection of C-Anca AntibodiesMOB · Traditional | 09/30/1996SE |
Questions and answers
When was Scimedx Phase II PR3 Igg Antibody Eia cleared by the FDA?
Scimedx Phase II PR3 Igg Antibody Eia (K010287) received a 510(k) decision of Substantially Equivalent on March 16, 2001, 44 days after the submission was received.
What is the product code of K010287?
The FDA product code is MOB – Test System, Antineutrophil Cytoplasmic Antibodies (Anca), a Class II (moderate risk) device regulated under 21 CFR 866.5660.